BRCA1 and ovarian cancer: The risk of ovarian cancer in BRCA1/2 pathogenic variant carriers can be significantly reduced by risk-reducing salpingo-oophorectomy (RRSO), with a reported hazard ratio (HR) of 0.06, compared with that in non-carriers who did not undergo the procedure [3].